Abnormal activation of NTRK3 and its fusion proteins may regulate the epithelial-mesenchymal transition (EMT) process, tumor growth rate and tumorigenicity by activating several signaling pathways [40]. This evidence concerns the gene NTRK3 and neoplasm.